AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission... ( Ignagni: This initiative is a fu...)

HOME >> MEDICINE >> NEWS

AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions

Date:12/19/2007

Ignagni: "This initiative is a fundamental repositioning."

WASHINGTON, Dec. 19 /PRNewswire-USNewswire/ -- One year ago America's Health Insurance Plans' (AHIP) Board of Directors advanced a proposal to provide universal coverage. Today, the Board released a proposal to guarantee access to health care coverage in the individual market and announced support for third party review of rescission decisions and their commitment to limiting pre-existing condition exclusions.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO )

"We are committed to working with legislators and other stakeholders to identify policy solutions to the health care challenges facing our nation," said George Halvorson, Chairman and CEO of Kaiser Permanente and Chairman of AHIP's Board of Directors.

The individual health insurance market continues to be the center of various reform proposals to expand access to health care coverage. Continuing on its mission to improve the accessibility, affordability, and quality of health care in America, in June the AHIP Board established an Individual Market Task Force to examine this issue and put forth both policy and operational recommendations.

The result is a three-part proposal that includes a plan to guarantee access to health care coverage to all Americans, new initiatives to give consumers peace of mind about individual health care coverage, and steps states need to take if they are considering a requirement for universal participation.

"Health plans from across the country came together to address the unique challenges facing the individual health insurance market. We believe that plans and the states, working together, can guarantee access to affordable insurance for everyone in the individual market," said Jay Gellert, President and CEO of Health Net, Inc. and Co-Chairman of the Individual Market Ta
'/>"/>

SOURCE America's Health Insurance Plans
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System

Post Your Comments:

(Date:5/13/2008)...-- United American Healthcare,Corporation (Nasdaq:...nagement services to a full-service managed care o...l results for its third fiscal quarter,ended March... million for the third fiscal,quarter ended March ...or,the third quarter of the prior fiscal year. The...

(Date:5/13/2008)...re-FirstCall/ -- IRIDEX,Corporation (Nasdaq: IRIX...quarter of 2008 ended March 29, 2008., Revenue fo...8.7%,decrease from the $12.6 million reported for ...was $0.9 million or $0.10 per diluted share for th...f $4.9 million or $0.61 per,diluted share in the f...

(Date:5/13/2008)... Ongoing; Company Prepares for, Potential 2008 Lau...llion in Quarter, G...iddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ),...d commercializing novel anti-infective products, t...or the quarter ended March 31,2008., MiddleBrook...

(Date:5/13/2008)... the poor from improving, study finds , ,...of care at hospitals that treat poor and underserv... lagging well behind hospitals that do not serve t...tals, which rely on state and federal funding from... to improve the quality of care at the same rate t...

[0] United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results [0] IRIDEX Reports First Quarter 2008 Financial Results [0] MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results [0] Quality Lags at Safety-Net Hospitals

...acteria known as E. coli 0157:H7 causes some of th...en and adults. Infections with this organism are o...udy shows using antibiotics to treat children with...he risk of developing a potentially deadly liver d...

...ysfunction is associated with loss of libido, low ...men who have attained their menopause or whose ova...Dehydroepiandosterone(DHEA), may serve as an effec...n, according to a study released at the 96th annua...

...cal Association (IMA) is embarking on an exercise ...country, according to Dr. Sanjiv Malik, Honorary S...so entered into an alliance with ORGMARG to create...ners in the country, be it allopathy or homeopathy...

...isclosure, Dr. Murali Ankem, a resident in Urology... University of New Jersey Medical and Dental Schoo...sed in prostate cancer treatment can migrate to ot...s. In a procedure called Brachytherapy, tiny metal...

Other Medicine News:

Antibiotic induces liver damage in children with E.COLI infections.New dimension in the treatment of female sexual dysfunction IMA to create database on physicians Radioactive Seeds used in Prostate Cancer treatment can migrate with the body

(Date:5/13/2008)...., May 13 /- Dried blood spots are em...serum collection and transport,for blood tests. In...l of,Diabetes Science and Technology (2008; 2(2):2...e use of dried blood spots is a "powerful tool", f...developing countries with,limited health budgets.,...

(Date:5/13/2008)... and BARCELONA, Spain, May 13 /PRNewswire-FirstCal...today welcomed two-year results,from the SPIRIT II...roven,long-term safety and efficacy of the market-...oronary Stent System and reinforce the growing bod... V (PROMUS(TM)),Everolimus-Eluting Coronary Stent ...

(Date:5/13/2008)...ted with XIENCE V in SPIRIT III Trial Experience B... Stent Thrombosis than Patients ... 13 /- Long-term data,prese...trial, Abbott,s U.S.,pivotal trial studying the XI...m, demonstrated that XIENCE V continues to deliver...

(Date:5/13/2008)...LIS, France, May 13 /- NicO...& Co., Inc. has initiated the,first in a series of...ertensive patients, under the companies, collabora...g antihypertensive agents using NicOx,proprietary...elected from,the companies, joint research program...

Breaking Medicine Technology:Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening 2 SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 2 SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 3 SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5 NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 2 NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc. 3 African medical research and training receives Wellcome boost 16519 1 African medical research and training receives Wellcome boost 16519 2 SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 1 SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 2 SAPPHIRE trial shows long term benefit of carotid stenting as alternative to surgery 16517 3 Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 1 Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 2 Study Showed Minimally Invasive Surgery Reduced Risk of Hospital Acquired Infections Compared to Open Surgery 16516 3 Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 1 Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 2 Rejuvasun 28TM 29 With Omnilux 28TM 29 3A Industry First to Feature FDA Cleared Clinically Proven Light Therapy Technology 16514 3

[0] Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening [0] SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents [0] XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years [0] NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.

...RE)--Jun 18, 2007 - Advanced Viral,Research Corp. ...company, announced today that preliminary findings...ow topical treatment with AVR118,appears to have c...ess associated with surgical incisions or dermatol...ological study is evaluating the,activity of a top...

...Influenza Conference , HIGH WYCOMBE, UK 18th June ...ing how a new flu vaccine has the potential,to pro...andemic and,annual, was presented today by PepTcel...a VI (Options) Conference, in Toronto,Canada. , T...n the,European Journal of Immunology, showed how m...

Other Medicine Technology:Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2 New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2 New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3 New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4 New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 5

Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study New Flu Vaccine from PepTcell Could Provide Immunity Against All,Strains of Influenza Virus

Tegagel hydrogel wound filler and Tegagel hydrogel wound filler with gauze are amorphous hydrogel dressings specially formulated to help provide a moist environment that has been shown to enhance wou

... physician preference card system as well as a per...ply management requirements of the surgical servic... with a broad array of inventory management capabi...suite supply and charge capture workflow. Regardle...

...rade; External Vacuum Therapy System restores sexu...ive and low cost vacuum therapy, coupled with its ..., makes it the ideal therapy for treating erectile... System causes penile rigidity that can be maintai...

Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand.

Medicine Products:

3M™ Tegagel™ Hydrogel Wound Filler OptiFlex SS ErecAid® Esteem™ External Vacuum Therapy System Osbon ErecAid Vacuum Therapy System - Manual

AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission...( Ignagni: This initiative is a fu...),Health